Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzylpenicillin (Penicillin G) and gentamicin is an antibiotic combination that provides synergistic activity against various bacterial infections. Benzylpenicillin is a natural penicillin that inhibits bacterial cell wall synthesis, while gentamicin is an aminoglycoside that inhibits protein synthesis in susceptible bacteria. This combination is particularly effective against group D streptococci, including Streptococcus faecalis (Enterococcus faecalis), and is commonly used for empirical treatment of neonatal sepsis, bacterial meningitis, and other serious infections. The synergistic effect occurs as penicillin increases bacterial cell wall permeability, facilitating gentamicin's access to its target site within the bacterial cell.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzylpenicillin + gentamicin.